Hu and his lab take biochemical, cell biological, and
immunological approaches to study these questions in mouse tumor models and human cancer cells.
Immune - based strategies to treat pancreatic cancer during the early stages of development, as well as new
immunological approaches to treat advanced disease, are showing significant promise where other approaches have failed.
The Cancer Research Institute funds research aimed at furthering the development of
immunological approaches to the diagnosis, treatment, and prevention of cancer.
«This new mechanism allows us to identify the weaknesses of our present
immunological approaches and to develop new weapons that are even more effective.
Not exact matches
For this
approach to work, the researchers reasoned that they would need to alter the
immunological conditions inside the surgical wound.
«Metabolomics provides new opportunities and a powerful
approach to investigate potential viral, host, pathogenic and
immunological determinants of dengue infection and pathogenesis,» explains Dr. Barry Beaty, from the Colorado State University.
We designed a three - pronged
approach for our coverage of
immunological diseases and disorders, interviewing clinicians, researchers, and patients, and the results so far have been terrific.
This novel
approach, which reveals complex interactions between cells and proteins, can also be used for other diseases to generate new knowledge about the regulation and dysregulation of the immune system, which can eventually give rise to new, improved
immunological therapies.
We will leverage this
approach, allied to cutting - edge microbiological and
immunological techniques in gnotobiotic mouse models of IBD, to identify and characterize the microbes that contribute to the development and pathogenesis of IBD, and the mechanisms underlying these interactions.
Therefore the group: i) characterizes the specificity of these antibody responses to identify relevant targets for a vaccine; ii) developes new
approaches to test antibody responses; and iii) adoptes the
immunological analysis in preclinical (in rabbits and macaques) and clinical vaccines studies to identify predictive signatures for the development and prioritization of new HIV - 1 vaccine candidates.
c. Epigenetic
approaches to primer for and / or synergize with
immunological therapy in epithelial ovarian cancer.
«The FDA approval of Provenge is a landmark for the field of cancer immunology and immunotherapy, adding strength to the concept of
immunological control of cancer and demonstrating the commercial viability of the
approach,» Old stated.